{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T09:01:15Z","timestamp":1791104475766,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jhep.2006.08.010","type":"journal-article","created":{"date-parts":[[2006,9,26]],"date-time":"2006-09-26T12:02:59Z","timestamp":1159272179000},"page":"107-114","source":"Crossref","is-referenced-by-count":81,"title":["Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma"],"prefix":"10.1016","volume":"46","author":[{"given":"Jian-Ying","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Megliorino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan-Xian","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng M.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward K.L.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2006.08.010_bib1","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1172\/JCI14451","article-title":"Autoantibodies as reporters identifying aberrant cellular mechanisms in tumorigenesis","volume":"108","author":"Tan","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2006.08.010_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1084\/jem.180.1.1","article-title":"Cancer antigens: immune recognition of self and altered self","volume":"180","author":"Houghton","year":"1994","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2006.08.010_bib3","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1084\/jem.187.8.1163","article-title":"New paths in human cancer serology","volume":"187","author":"Old","year":"1998","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2006.08.010_bib4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1172\/JCI116848","article-title":"Novel nuclear antoantigen with splicing factor motifs identified with antibody from hepatocellular carcinoma","volume":"92","author":"Imai","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2006.08.010_bib5","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1084\/jem.189.7.1101","article-title":"A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma","volume":"189","author":"Zhang","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2006.08.010_bib6","doi-asserted-by":"crossref","first-page":"5006","DOI":"10.1038\/sj.onc.1205625","article-title":"Cloning and characterization of a novel 90kDa \u2018companion\u2019 auto-antigen of p62 overexpressed in cancer","volume":"21","author":"Soo Hoo","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2006.08.010_bib7","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/ijc.2910300404","article-title":"Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer","volume":"30","author":"Crawford","year":"1982","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jhep.2006.08.010_bib8","first-page":"1777","article-title":"p53 antibodies in the sera of patients with various types of cancer. A review","volume":"60","author":"Soussi","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.jhep.2006.08.010_bib9","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1600-065X.1995.tb00076.x","article-title":"Immunity to oncogenic proteins","volume":"145","author":"Cheever","year":"1995","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jhep.2006.08.010_bib10","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1200\/JCO.1997.15.11.3363","article-title":"High-titer HER-2\/neu protein-specific antibody can be detected in patients with early-stage breast cancer","volume":"15","author":"Disis","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2006.08.010_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/hep.510250114","article-title":"Immune response to cyclin B1 in hepatocellular carcinoma","volume":"25","author":"Covini","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2006.08.010_bib12","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1084\/jem.194.9.1313","article-title":"Identification of cyclin B1 as a shared human epithelial tumor-associated antigen recognized by T cells","volume":"194","author":"Kao","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jhep.2006.08.010_bib13","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0002-9440(10)61770-1","article-title":"Aberrant expression of fetal RNA-binding protein p62 in liver cancer and liver cirrhosis","volume":"159","author":"Lu","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jhep.2006.08.010_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/1097-0142(19930101)71:1<26::AID-CNCR2820710106>3.0.CO;2-N","article-title":"Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma","volume":"71","author":"Imai","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.jhep.2006.08.010_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1365-2249.2001.01585.x","article-title":"De novo humoral immune responses to cancer-associated autoantigens during transition from chronic liver disease to hepatocellular carcinoma","volume":"125","author":"Zhang","year":"2001","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jhep.2006.08.010_bib16","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0168-8278(97)80460-6","article-title":"Diversity of antinuclear antibody responses in hepatocellular carcinoma","volume":"26","author":"Covini","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2006.08.010_bib17","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1023\/A:1014483803483","article-title":"Autoimmune responses in Chinese hepatocellular carcinoma (HCC)","volume":"22","author":"Zhang","year":"2002","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.jhep.2006.08.010_bib18","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1007\/BF01297149","article-title":"Hepatocellular carcinoma. A worldwide problem and the major risk factors","volume":"36","author":"Simonetti","year":"1991","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhep.2006.08.010_bib19","doi-asserted-by":"crossref","first-page":"7121","DOI":"10.1073\/pnas.94.14.7121","article-title":"Hepatitis B virus, the vaccine, and the control of primary cancer of the liver","volume":"94","author":"Blumberg","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.jhep.2006.08.010_bib20","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.antiviral.2003.08.010","article-title":"Etiology, natural history and treatment of hepatocellular carcinoma","volume":"60","author":"Colombo","year":"2003","journal-title":"Antiviral Res"},{"key":"10.1016\/j.jhep.2006.08.010_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1055\/s-2005-871195","article-title":"Prevention of hepatocellular carcinoma","volume":"25","author":"Colombo","year":"2005","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhep.2006.08.010_bib22","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/ije\/27.4.574","article-title":"A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China","volume":"27","author":"Zhang","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.jhep.2006.08.010_bib23","doi-asserted-by":"crossref","first-page":"947","DOI":"10.4269\/ajtmh.1998.59.947","article-title":"A case-control study of risk factors for hepatocellular carcinoma in Henan, China","volume":"59","author":"Zhang","year":"1998","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jhep.2006.08.010_bib24","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/bjc.1997.39","article-title":"\u2019Hepatoma-specific\u2019 alphafetoprotein may permit preclinical diagnosis of malignant change in patients with chronic liver disease","volume":"75","author":"Johnson","year":"1997","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jhep.2006.08.010_bib25","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1038\/sj.onc.1201110","article-title":"Cloning of a gene highly overexpressed in cancer coding for a novel KH-domain containing protein","volume":"14","author":"Muller-Pillasch","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.jhep.2006.08.010_bib26","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","article-title":"A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development","volume":"19","author":"Nielsen","year":"1999","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.jhep.2006.08.010_bib27","series-title":"Manual of clinical laboratory immunology","first-page":"935","article-title":"Enzyme-linked immunosorbent assays for antibodies to native DNA, histones, and (H2A-H2B)-DNA","author":"Rubin","year":"1997"},{"key":"10.1016\/j.jhep.2006.08.010_bib28","series-title":"Manual of clinical laboratory immunology","first-page":"928","article-title":"Detection of autoantibodies to ribonucleoprotein particles by immunoblotting","author":"Chan","year":"1997"},{"key":"10.1016\/j.jhep.2006.08.010_bib29","series-title":"Epidemiology","first-page":"63","article-title":"Assessing the validity and reliability of diagnostic and screening tests","author":"Gordis","year":"2000"},{"key":"10.1016\/j.jhep.2006.08.010_bib30","first-page":"136","article-title":"Enhancement of antibody detection in cancer using panel of recombinant tumor-associated antigens","volume":"12","author":"Zhang","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.jhep.2006.08.010_bib31","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/366704a0","article-title":"A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D\/CDK4","volume":"366","author":"Serrano","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2006.08.010_bib32","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1056\/NEJMoa051931","article-title":"Autoantibody signatures in prostate cancer","volume":"353","author":"Wang","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhep.2006.08.010_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000011953","article-title":"Infrequent presence of anti-c-Myc antibodies and absence of c-Myc oncoprotein in sera from lung cancer patients","volume":"56","author":"Yamamoto","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.jhep.2006.08.010_bib34","doi-asserted-by":"crossref","first-page":"4332","DOI":"10.1158\/1078-0432.CCR-04-0181","article-title":"Spontaneous tumor-specific humoral and cellular immune responses to NY-ESO-1 in hepatocellular carcinoma","volume":"10","author":"Korangy","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2006.08.010_bib35","first-page":"5120","article-title":"Recursive partitioning as an approach to selection of immune markers for tumor diagnosis","volume":"9","author":"Koziol","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2006.08.010_bib36","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/pros.20181","article-title":"Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens","volume":"63","author":"Shi","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.jhep.2006.08.010_bib37","first-page":"1079","article-title":"Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma","volume":"27","author":"Himoto","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.jhep.2006.08.010_bib38","series-title":"Immunology and liver","first-page":"8","article-title":"Autoantibodies to insulin-like growth factor II mRNA-binding proteins in hepatocellular carcinoma","author":"Tan","year":"2000"},{"key":"10.1016\/j.jhep.2006.08.010_bib39","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.humpath.2003.07.005","article-title":"Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival","volume":"34","author":"Feakins","year":"2003","journal-title":"Hum Pathol"},{"key":"10.1016\/j.jhep.2006.08.010_bib40","first-page":"977","article-title":"Overexpression of the cyclin-dependent kinase inhibitor p16 is associated with tumor recurrence in human prostate cancer","volume":"5","author":"Lee","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2006.08.010_bib41","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.3748\/wjg.v9.i10.2202","article-title":"Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma","volume":"9","author":"Zhao","year":"2003","journal-title":"World J Gastroenterol"}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806004958?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827806004958?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,21]],"date-time":"2019-04-21T09:40:40Z","timestamp":1555839640000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827806004958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0168827806004958"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2006.08.010","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}